Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $42000.0.

  • Assembly Biosciences' Capital Expenditures changed N/A to $42000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $42000.0, marking a year-over-year decrease of 5757.58%. This contributed to the annual value of $28000.0 for FY2024, which is 8901.96% down from last year.
  • Assembly Biosciences' Capital Expenditures amounted to $42000.0 in Q3 2025.
  • Assembly Biosciences' 5-year Capital Expenditures high stood at $3.1 million for Q1 2021, and its period low was $14000.0 during Q1 2024.
  • Over the past 5 years, Assembly Biosciences' median Capital Expenditures value was $48000.0 (recorded in 2023), while the average stood at $391444.4.
  • In the last 5 years, Assembly Biosciences' Capital Expenditures skyrocketed by 463538.46% in 2021 and then plummeted by 7083.33% in 2024.
  • Over the past 5 years, Assembly Biosciences' Capital Expenditures (Quarter) stood at $18000.0 in 2021, then surged by 466.67% to $102000.0 in 2022, then crashed by 30.39% to $71000.0 in 2023, then crashed by 80.28% to $14000.0 in 2024, then surged by 200.0% to $42000.0 in 2025.
  • Its Capital Expenditures stands at $42000.0 for Q3 2025, versus $14000.0 for Q2 2024 and $14000.0 for Q1 2024.